About
Oriva Therapeutics is a clinical-stage women's health biotechnology company based in Barcelona developing disease-modifying therapies for chronic gynecological conditions. Its pipeline includes advanced programs targeting endometriosis and uterine fibroids via novel chemistry against validated biological pathways.
Explore Oriva Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.